Siegfried Holding AG (XSWX:SFZN)
CHF 69.65 +1.1 (+1.6%) Market Cap: 3.05 Bil Enterprise Value: 2.95 Bil PE Ratio: 18.15 PB Ratio: 2.70 GF Score: 94/100

Full Year 2024 Siegfried Holding AG Earnings Call Transcript

Feb 18, 2025 / 01:00PM GMT
Release Date Price: CHF98.9 (-6.34%)

Key Points

Positve
  • Siegfried Holding AG (XSWX:SFZN) achieved a core EBITDA margin of 22.1% and a core net profit increase of 24%, reaching close to CHF160 million.
  • The company successfully reduced carbon emissions by 50% over the last four years, demonstrating significant progress in sustainability.
  • Siegfried Holding AG expanded its network in the USA with the acquisition of the Grafton site in Wisconsin, enhancing its service offerings.
  • Operational excellence initiatives, including the EVOLVE+ strategy, contributed to strong performance in safety, quality, and supply reliability, with a supply reliability rate exceeding 90%.
  • The company maintained a diverse management team, with 48% of management positions held by women, and continued to focus on diversity and inclusion.
Negative
  • The phasing out of the vaccines business resulted in a revenue impact of CHF30 million to CHF40 million.
  • Currency headwinds, particularly the depreciation of the dollar and euro against the Swiss franc, negatively affected the business portfolio by 1.2%.
  • The company faced challenges with destocking, which had a financial impact of CHF20 million to CHF30 million in 2024, with some effects expected to continue into 2025.
  • Operating cash flow was lower in 2024 compared to 2023, partly due to a one-time increase in paid income taxes related to COVID-related profits in Germany.
  • The company anticipates a mid-single-digit growth in local currencies for 2025, which is lower than the 8% to 9% growth achieved in 2024, partly due to ongoing destocking effects.
Peter Stierli
Siegfried Holding AG - Head Corporate Communications

(video playing)

Welcome to the presentation of our full year results 2024. A warm welcome also to the ones who have joined online. Thanks for joining. With me today is Marcel Imwinkelried, our CEO; and Reto Suter, our CFO.

As always, we will start with a summary of the highlights of 2024. Reto will then talk about the financials in more detail. Then Marcel will talk about what is driving the growth in our key market segments, some of the trends in our industry, and how we are implementing EVOLVE+ to position ourselves in this environment. At the end we will have a Q&A session. Those who join online can join via and ask the questions via video call.

With that, I would like to hand over to Marcel. Over to you.

Marcel Imwinkelried
Siegfried Holding AG - Chief Executive Officer and Chief Operating Officer Drug Products

Thank you, Peter. Good afternoon. Happy to meet you in person here in Zurich. And also a warm welcome to the colleagues which have joined in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot